| Pyter, Leah M |
Ohio State University
United States |
Chemotherapy-induced circadian master clock disruptions and fatigue |
3R01CA270372-02S1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
| Rosser, Charles J |
Cedars-Sinai Medical Center
United States |
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology |
5R01CA277810-02 |
|
| Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
The UCLA Center in Early Detection of Liver Cancer |
2U01CA230705-06 |
|
| Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
Multi-cancer early detection using cell-free DNA methylome analysis |
1U01CA285010-01 |
|
| Garcia, Jose M. |
Seattle Inst For Biomedical/Clinical Res
United States |
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) |
1R01CA279220-01A1 |
|
| Conley, Yvette P |
University Of Pittsburgh At Pittsburgh
United States |
Epigenomics of Neurocognitive Function in Breast Cancer |
5R01CA221882-05 |
|
| Kleckner, Ian Robert |
University Of Maryland Baltimore
United States |
Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation |
5R21CA259422-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
| Figueiredo, Jane C. |
Cedars-Sinai Medical Center
United States |
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 |
3U54CA260591-02S3 |
|
| Eibl, Guido Erwin Michael |
University Of California Los Angeles
United States |
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma |
5P01CA236585-04 |
PAR-18-290 (P01 Clinical Trial Optional) |
| Goggins, Michael G. |
Johns Hopkins University
United States |
Using Markers to Improve Pancreatic Cancer Screening |
5R01CA176828-09 |
|